Analysts covering Oracle Corporation (NYSE: ORCL) expect its revenue to more than double within two years, reaching $183.81 billion by fiscal 2029 from $90.42 billion in fiscal 2027.

Yet the stock sits at just 15.5 times this fiscal year’s earnings estimate, a multiple that looks cheap for a business Wall Street projects will grow normalized EPS by 93.7% over the same period.

The disconnect has a clear explanation: Oracle is spending at a scale that has pushed free cash flow deeply negative, and investors are waiting for clarity on when that reverses.

Capital expenditures reached $28 billion in the most recent period, leaving the company with negative $5 billion in free cash flow as it races to build out AI data center infrastructure.

Oracle has guided for $90 billion to $95 billion in total capital spending this fiscal year, a commitment that is simultaneously the source of its growth potential and its credit pressure.

S&P Global cut Oracle’s credit rating to BBB-, just one notch above junk status, reflecting concern about the financial strain of that construction program.

Five-year credit default swaps, a market measure of default risk, hit a record high on September 24 and were again approaching record levels as recently as October 22, according to Reuters.

The September 24 spike followed Oracle’s force majeure notice to Blue Owl (NYSE: OWL), the firm building Project Jupiter, its New Mexico data campus, citing potential delays in securing adequate power supply.

Oracle shares dropped 3.5% that day, though the company subsequently announced on October 22 that a Bloom Energy (NYSE: BE) fuel-cell microgrid of up to 2.45 gigawatts would replace the site’s originally planned gas turbines and diesel generators.

The credit and infrastructure turbulence has overshadowed a run of strong operating results, with Oracle beating Wall Street’s adjusted earnings-per-share estimate in each of the last four quarters.

Fiscal first-quarter results released September 10 showed cloud infrastructure revenue surging 121% to $7.4 billion, with total revenue climbing 30% to $19.3 billion and adjusted EPS of $1.92 clearing the $1.74 consensus.

Earlier in June, Oracle posted fiscal fourth-quarter adjusted EPS of $2.11 against a $1.96 estimate, sending shares to nearly $248 before a sharp reversal brought the stock down to around $116 by late July.

From a starting point near $280 roughly one year ago, Oracle shares closed at $126.16 on October 23, a decline of approximately 55% despite the unbroken string of earnings beats.

The single question that matters most to investors is when free cash flow turns positive, a point CFO Hilary Maxson declined to commit to on the September earnings call, saying “We haven’t given a particular time frame on that yet, and we don’t expect to give that today.”

Maxson indicated that Oracle’s Investor Day, scheduled for October 28 at AI World, would include additional detail on margins, giving shareholders their next opportunity to assess the funding timeline.

The December 14 quarterly report represents the following major catalyst, with Oracle having guided for revenue growth of 30% to 34% and non-GAAP EPS in the range of $1.85 to $1.93.

Normalized EPS estimates through fiscal 2029 stand at $8.14, $10.99, and $15.77 respectively, meaning the stock currently trades at just 8 times the earnings analysts expect three years out.

Whether that represents a genuine bargain or a value trap hinges almost entirely on whether management can establish a credible timeline for its cash flow inflection at the upcoming investor event.